PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
Brookline Capital Initiates Marker Therapeutics(MRKR.US) With Buy Rating, Announces Target Price $4
Marker Therapeutics Initiated With a Buy at Brookline
Ladenburg Thalmann Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Raises Target Price to $19
Marker Therapeutics Analyst Ratings
Marker Therapeutics Analyst Ratings
Piper Sandler Adjusts Marker Therapeutics' Price Target to $1.50 From $3.50, Reiterates Overweight Rating